Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy
LuLu Jiang
1
,
Weiwei Lin
2
,
Cheng Zhang
3
,
P. E. A. Ash
1
,
Mamta Verma
1
,
Julian Kwan
2
,
Emily Van Vliet
1
,
Zhuo Yang
1
,
Anna Lourdes Cruz
1
,
Samantha Boudeau
1
,
Brandon F Maziuk
1
,
Shuwen Lei
1
,
Jaehyup Song
1
,
Victor E. Alvarez
4
,
Stacy Hovde
5
,
Jose F. Abisambra
6
,
Min Hao Kuo
5
,
Nicholas M. Kanaan
7
,
M. M. Murray
8
,
John F. Crary
9
,
Jian Xun Zhao
10
,
Ji Cheng
10
,
Leonard Petrucelli
8
,
Hu Li Hu Li
3
,
Andrew Emili
2
,
9
Department of Pathology, Mount Sinai Medical Center, New York, NY, 10029, USA.
|
Publication type: Journal Article
Publication date: 2021-10-01
scimago Q1
wos Q1
SJR: 9.051
CiteScore: 24.4
Impact factor: 16.6
ISSN: 10972765, 10974164
PubMed ID:
34453888
Molecular Biology
Cell Biology
Abstract
The microtubule-associated protein tau oligomerizes, but the actions of oligomeric tau (oTau) are unknown. We have used Cry2-based optogenetics to induce tau oligomers (oTau-c). Optical induction of oTau-c elicits tau phosphorylation, aggregation, and a translational stress response that includes stress granules and reduced protein synthesis. Proteomic analysis identifies HNRNPA2B1 as a principle target of oTau-c. The association of HNRNPA2B1 with endogenous oTau was verified in neurons, animal models, and human Alzheimer brain tissues. Mechanistic studies demonstrate that HNRNPA2B1 functions as a linker, connecting oTau with N6-methyladenosine (m6A) modified RNA transcripts. Knockdown of HNRNPA2B1 prevents oTau or oTau-c from associating with m6A or from reducing protein synthesis and reduces oTau-induced neurodegeneration. Levels of m6A and the m6A-oTau-HNRNPA2B1 complex are increased up to 5-fold in the brains of Alzheimer subjects and P301S tau mice. These results reveal a complex containing oTau, HNRNPA2B1, and m6A that contributes to the integrated stress response of oTau.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
bioRxiv
12 publications, 7.64%
|
|
|
International Journal of Molecular Sciences
5 publications, 3.18%
|
|
|
Alzheimer's and Dementia
4 publications, 2.55%
|
|
|
Journal of Biological Chemistry
4 publications, 2.55%
|
|
|
Signal Transduction and Targeted Therapy
3 publications, 1.91%
|
|
|
Molecular Neurodegeneration
3 publications, 1.91%
|
|
|
Brain Pathology
3 publications, 1.91%
|
|
|
Nature Communications
3 publications, 1.91%
|
|
|
Science advances
2 publications, 1.27%
|
|
|
Essays in Biochemistry
2 publications, 1.27%
|
|
|
Cells
2 publications, 1.27%
|
|
|
Biomedicines
2 publications, 1.27%
|
|
|
Frontiers in Genetics
2 publications, 1.27%
|
|
|
Molecular Psychiatry
2 publications, 1.27%
|
|
|
Acta Neuropathologica
2 publications, 1.27%
|
|
|
Progress in Neurobiology
2 publications, 1.27%
|
|
|
Aging Cell
2 publications, 1.27%
|
|
|
Research square
2 publications, 1.27%
|
|
|
Human Molecular Genetics
2 publications, 1.27%
|
|
|
Neural Regeneration Research
2 publications, 1.27%
|
|
|
Nature Neuroscience
2 publications, 1.27%
|
|
|
iScience
2 publications, 1.27%
|
|
|
Neuroscientist
1 publication, 0.64%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 publication, 0.64%
|
|
|
Nature Reviews Molecular Cell Biology
1 publication, 0.64%
|
|
|
Journal of Comparative Neurology
1 publication, 0.64%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 0.64%
|
|
|
Biochemical Society Transactions
1 publication, 0.64%
|
|
|
Trends in Cell Biology
1 publication, 0.64%
|
|
|
2
4
6
8
10
12
|
Publishers
|
5
10
15
20
25
30
35
|
|
|
Cold Spring Harbor Laboratory
35 publications, 22.29%
|
|
|
Springer Nature
27 publications, 17.2%
|
|
|
Elsevier
25 publications, 15.92%
|
|
|
Wiley
18 publications, 11.46%
|
|
|
MDPI
11 publications, 7.01%
|
|
|
Frontiers Media S.A.
7 publications, 4.46%
|
|
|
Portland Press
4 publications, 2.55%
|
|
|
Oxford University Press
4 publications, 2.55%
|
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 1.27%
|
|
|
American Society for Biochemistry and Molecular Biology
2 publications, 1.27%
|
|
|
Hindawi Limited
2 publications, 1.27%
|
|
|
SAGE
1 publication, 0.64%
|
|
|
Walter de Gruyter
1 publication, 0.64%
|
|
|
American Society for Clinical Investigation
1 publication, 0.64%
|
|
|
Taylor & Francis
1 publication, 0.64%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.64%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.64%
|
|
|
Annual Reviews
1 publication, 0.64%
|
|
|
Medknow
1 publication, 0.64%
|
|
|
American Society for Microbiology
1 publication, 0.64%
|
|
|
American Chemical Society (ACS)
1 publication, 0.64%
|
|
|
AME Publishing Company
1 publication, 0.64%
|
|
|
Spandidos Publications
1 publication, 0.64%
|
|
|
Life Science Alliance, LLC
1 publication, 0.64%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.64%
|
|
|
5
10
15
20
25
30
35
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
157
Total citations:
157
Citations from 2024:
82
(52.23%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Jiang L. et al. Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy // Molecular Cell. 2021. Vol. 81. No. 20. p. 4209-4227.e12.
GOST all authors (up to 50)
Copy
Jiang L., Lin W., Zhang C., Ash P. E. A., Verma M., Kwan J., Van Vliet E., Yang Z., Cruz A. L., Boudeau S., Maziuk B. F., Lei S., Song J., Alvarez V. E., Hovde S., Abisambra J. F., Kuo M. H., Kanaan N. M., Murray M. M., Crary J. F., Zhao J. X., Cheng J., Petrucelli L., Hu Li H. L., Emili A., Wolozin B. L. Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy // Molecular Cell. 2021. Vol. 81. No. 20. p. 4209-4227.e12.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.molcel.2021.07.038
UR - https://doi.org/10.1016/j.molcel.2021.07.038
TI - Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy
T2 - Molecular Cell
AU - Jiang, LuLu
AU - Lin, Weiwei
AU - Zhang, Cheng
AU - Ash, P. E. A.
AU - Verma, Mamta
AU - Kwan, Julian
AU - Van Vliet, Emily
AU - Yang, Zhuo
AU - Cruz, Anna Lourdes
AU - Boudeau, Samantha
AU - Maziuk, Brandon F
AU - Lei, Shuwen
AU - Song, Jaehyup
AU - Alvarez, Victor E.
AU - Hovde, Stacy
AU - Abisambra, Jose F.
AU - Kuo, Min Hao
AU - Kanaan, Nicholas M.
AU - Murray, M. M.
AU - Crary, John F.
AU - Zhao, Jian Xun
AU - Cheng, Ji
AU - Petrucelli, Leonard
AU - Hu Li, Hu Li
AU - Emili, Andrew
AU - Wolozin, B. L.
PY - 2021
DA - 2021/10/01
PB - Elsevier
SP - 4209-4227.e12
IS - 20
VL - 81
PMID - 34453888
SN - 1097-2765
SN - 1097-4164
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Jiang,
author = {LuLu Jiang and Weiwei Lin and Cheng Zhang and P. E. A. Ash and Mamta Verma and Julian Kwan and Emily Van Vliet and Zhuo Yang and Anna Lourdes Cruz and Samantha Boudeau and Brandon F Maziuk and Shuwen Lei and Jaehyup Song and Victor E. Alvarez and Stacy Hovde and Jose F. Abisambra and Min Hao Kuo and Nicholas M. Kanaan and M. M. Murray and John F. Crary and Jian Xun Zhao and Ji Cheng and Leonard Petrucelli and Hu Li Hu Li and Andrew Emili and B. L. Wolozin},
title = {Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy},
journal = {Molecular Cell},
year = {2021},
volume = {81},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016/j.molcel.2021.07.038},
number = {20},
pages = {4209--4227.e12},
doi = {10.1016/j.molcel.2021.07.038}
}
Cite this
MLA
Copy
Jiang, LuLu, et al. “Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy.” Molecular Cell, vol. 81, no. 20, Oct. 2021, pp. 4209-4227.e12. https://doi.org/10.1016/j.molcel.2021.07.038.